BioSpace News Archive

BioLife Solutions today announced that its customer Kite Pharma has received US FDA approval for Yescarta, the first CAR T-cell therapy for treatment of adult patients with relapsed or refractory large B-Cell lymphoma after two or more lines of systemic therapy.

J&J today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2017 of $0.84 per share on the company’s common stock.

Biscayne Neurotherapeutics announced results from a Phase 1b trial of its novel antiepileptic compound, BIS-001ER.

Second Sight Medical Products announced the appointment of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific, where he will lead all commercial activities for the Company outside of North America.

Esanex, Inc., a clinical stage company developing Heat Shock Protein inhibitors for the treatment of cancer, today announced the first patient has been dosed in an open-label study of SNX-5422 added to ibrutinib.

Celgene announced that new data on the efficacy and safety of ozanimod, a novel, oral, selective, sphingosine 1-phosphate 1 (S1PR1) and 5 (S1PR5) receptor modulator, in relapsing multiple sclerosis (RMS) were accepted for the MSParis2017 - 7th Joint ECTRIMS - ACTRIMS Meeting, which is being held in Paris, October 25-28, 2017.

Marapharm Ventures announces that it has today filed an early warning report advising that it has purchased a total of 1,500,000 units of Veritas Pharma at a purchase price of $0.28 per unit.

Imprimis today announced it is making compounded Cyclosporine-based formulations available for physicians to consider prescribing as customizable and potentially lower-cost alternatives to Restasis.

Accuray announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy System by University Hospital of Tours (CHU).

Today at the ASHG Annual Meeting, Edico Genome and Fabric Genomics announced their collaboration to provide an integrated solution for secondary and tertiary analysis of next-generation sequencing data.